Difference between revisions of "Template:Main Page/News"

From WikiChem
Jump to: navigation, search
(Upload story)
 
 
(6 intermediate revisions by 2 users not shown)
Line 1: Line 1:
==Improving access to journals in needy countries==
+
*04-07: A mild, selective functionalisation of the terminal position of [[n-Pentane|''n''-pentane]] has been observed in a tungsten [[Metal nitrosyl|nitrosyl complex]]. The work was performed by a group at the [[University of British Columbia]], led by [[Peter Legzdins]].  [http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/ja0713633 DOI:10.1021/ja0713633]
The [[Royal Society of Chemistry]] is now offering [http://www.rsc.org/Publishing/Journals/News/freeaccess.asp free access for all readers] to two new journals, Soft Matter and Molecular BioSystems.  It has also made its back catalogue (from 1841) [http://www.rsc.org/chemistryworld/News/2006/March/01030602.asp freely available for African users.  Meanwhile the [[American Chemical Society]] is making its journals [[http://pubs.acs.org/pressrelease/iraq/library.html available to Iraqi users]] at a deep discount.
+
[[Image:PentaneActivation.png|center|450px|Functionalisation of n-pentane]]
 +
 
 +
*02-19: A new chapter in the history of [[quinine total synthesis]]: in an extensive [[Angewandte Chemie]] review, Jeffrey Seeman validates the 1944 quinine synthesis by [[Robert Burns Woodward|Bob Woodward]] and [[William von Eggers Doering|William Doering]].
 +
 
 +
*02-07: [[University of Pennsylvania]] chemist [[Alan MacDiarmid]] died on February 7th at the age of 79.  MacDiarmid is best known for the discovery and development of [[Conductive polymer|conductive polymers]] such as doped [[polyacetylene]], work for which he shared the 2000 [[Nobel Prize for Chemistry]].
 +
 
 +
*01-23: Pharmaceutical giant [[Pfizer]] announced a major restructuring plan, involving the loss of 10,000 jobs worldwide, after the failure of [[Torcetrapib]] in clinical trials.  The $7bn. [[Research and development|R&D]] budget remains intact, but in future Pfizer aims to bring in more externally sourced drug candidates.
 +
 
 +
{| class="noprint" width="100%"  border="0" style="padding: 0; margin: 0; background-color:transparent"
 +
|<div style="text-align:left; margin-bottom:4px">'''[[Template:Main Page/News#Archive|...Archive]]'''</div>
 +
|}<noinclude>
 +
 
 +
== Archive ==
 +
 
 +
*11-17: Researchers at [[University of Windsor]] report a non-metal phosphonium-borate displaying reversible [[hydrogen storage]].
 +
[[Image:Phosphinoboranehydrogenstorage 2.png|center|250px|Phosphino borane hydrogen storage]]
 +
:[[Hydrogen_storage#Research|Read more...]]
 +
*10-14: Researchers working at the [[Joint Institute for Nuclear Research]] ([[JINR]]) in [[Dubna]], [[Russia]], announced in ''[[Physical Review]] C'' that they had indirectly detected ununoctium-294 produced via collisions of [[californium]]-249 atoms and [[calcium]]-48 ions.  The element is a [[noble gas]], predicted to be more reactive than [[radon]]. Earlier American claims for this element were retracted, because key data had been fabricated by principal author [[Victor Ninov]]. [http://en.wikinews.org/wiki/Controversy-Plagued_Element_118%2C_the_Heaviest_Atom_Yet%2C_Finally_Discovered Read more...]
 +
 
 +
'''Improving access to journals in needy countries'''
 +
 
 +
The [[Royal Society of Chemistry]] is now offering [http://www.rsc.org/Publishing/Journals/News/freeaccess.asp free access for all readers] to two new journals, Soft Matter and Molecular BioSystems.  It has also made its back catalogue (from 1841) [http://www.rsc.org/chemistryworld/News/2006/March/01030602.asp] freely available for African users.  Meanwhile the [[American Chemical Society]] is making its journals [http://pubs.acs.org/pressrelease/iraq/library.html available to Iraqi users] at a deep discount.
 +
 
 +
[[Category:Main Page]]
 +
</noinclude>

Latest revision as of 09:37, 31 July 2009

Functionalisation of n-pentane
  • 01-23: Pharmaceutical giant Pfizer announced a major restructuring plan, involving the loss of 10,000 jobs worldwide, after the failure of Torcetrapib in clinical trials. The $7bn. R&D budget remains intact, but in future Pfizer aims to bring in more externally sourced drug candidates.

Archive

Phosphino borane hydrogen storage
Read more...

Improving access to journals in needy countries

The Royal Society of Chemistry is now offering free access for all readers to two new journals, Soft Matter and Molecular BioSystems. It has also made its back catalogue (from 1841) [1] freely available for African users. Meanwhile the American Chemical Society is making its journals available to Iraqi users at a deep discount.